Literature DB >> 1965794

Type IV collagenases in tumor invasion and metastasis.

W G Stetler-Stevenson1.   

Abstract

The invasion and metastasis of cancer cells is a complex multistep process involving destruction of basement membranes as an early event in the metastatic cascade. Recent evidence implicates secreted matrix metalloproteinase enzymes, such as type IV collagenases, as playing a central role in this tumor cell mediated extracellular matrix proteolysis. Two distinct type IV collagenase enzymes are now recognized. Immunohistochemical and biochemical studies of several human tumors show correlations between invasive potential and the 72 kDa type IV collagenase enzyme. Studies in rodent tumor models suggest that the 92 kDa type IV collagenase may play an important role in these models, but data on human tumors and human tumor tissue is lacking. Evidence suggest that the regulation of the 72 kDa type IV collagenase enzyme activity may occur at many levels, including transcriptional mechanisms, extracellular activation of latent enzyme and specific inhibitors of active enzyme. Thus the invasion of human tumor cells through basement membranes may be the result of net type IV collagenolytic activity that is the result of a balance of activated enzyme species and inhibitors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965794     DOI: 10.1007/bf00049520

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  84 in total

1.  Multilocus molecular mapping of the mouse X chromosome.

Authors:  L J Mullins; S G Grant; D A Stephenson; V M Chapman
Journal:  Genomics       Date:  1988-10       Impact factor: 5.736

Review 2.  Role of oncogenes in metastases.

Authors:  R Muschel; L A Liotta
Journal:  Carcinogenesis       Date:  1988-05       Impact factor: 4.944

3.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

4.  Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues.

Authors:  W G Stetler-Stevenson; P D Brown; M Onisto; A T Levy; L A Liotta
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

5.  Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.

Authors:  M Nakajima; D Lotan; M M Baig; R M Carralero; W R Wood; M J Hendrix; R Lotan
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

6.  Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.

Authors:  C Monteagudo; M J Merino; J San-Juan; L A Liotta; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

7.  Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

Authors:  G I Goldberg; B L Marmer; G A Grant; A Z Eisen; S Wilhelm; C S He
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.

Authors:  R J Muschel; J E Williams; D R Lowy; L A Liotta
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

9.  Tumour basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance.

Authors:  S J Forster; I C Talbot; D G Clayton; D R Critchley
Journal:  Int J Cancer       Date:  1986-06-15       Impact factor: 7.396

10.  Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid.

Authors:  H G Welgus; G P Stricklin
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

View more
  119 in total

1.  Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Authors:  E Louis; C Ribbens; A Godon; D Franchimont; D De Groote; N Hardy; J Boniver; J Belaiche; M Malaise
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.

Authors:  Y Jo; J Yeon; H J Kim; S T Lee
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

3.  MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.

Authors:  A M Tester; N Ruangpanit; R L Anderson; E W Thompson
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 4.  The role of cellular proteases and their inhibitors in invasion and metastasis. Introductionary overview.

Authors:  L Liotta
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

5.  Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.

Authors:  E Levi; R Fridman; H Q Miao; Y S Ma; A Yayon; I Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9.

Authors:  Hyereen Kang; Sung-Wuk Jang; Jesang Ko
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

7.  Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice.

Authors:  S J Kim; H Uehara; T Karashima; M Mccarty; N Shih; I J Fidler
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

8.  Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway.

Authors:  Wen Zheng; Shiliu Lu; Haolei Cai; Muxing Kang; Wenjie Qin; Chao Li; Yulian Wu
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

9.  Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.

Authors:  A Kawashima; I Nakanishi; H Tsuchiya; A Roessner; K Obata; Y Okada
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.

Authors:  S Gilbertson-Beadling; E A Powers; M Stamp-Cole; P S Scott; T L Wallace; J Copeland; G Petzold; M Mitchell; S Ledbetter; R Poorman
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.